CS logo
small CS logo
Institut Curie - Ulm - Paris

Paris Cedex 5, France
Cancer treatment center in Paris
26 Rue d'Ulm, 75005 Paris

About Institut Curie - Ulm - Paris


"L’Institut Curie, acteur de référence de la lutte contre le cancer, associe un Centre de Recherche de renommée internationale et un Ensemble Hospitalier de pointe qui prend en charge tous les cancers, y compris les plus rares. Fondé en 1909 par Marie Curie, l’Institut Curie rassemble sur trois sites (Paris, Saint-Cloud, Orsay) plus de 3 300 chercheurs, médecins et soignants autour de trois missions : la recherche, les soins et la conservation et la transmission des savoirs. Fondation privée reconnue d’utilité publique habilitée à recevoir des dons et des legs, l’Institut Curie peut, grâce au soutien de ses donateurs, favoriser les découvertes et ainsi améliorer les traitements et la qualité de vie des malades."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Total Rows: 1

Clinical Trials at Institut Curie - Ulm - Paris


During the past decade, Institut Curie - Ulm - Paris conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
2015-12-16
2026-09-22
Recruiting
155
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
2021-10-25
2025-12-31
Recruiting
340

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBayer: 2Bayer: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Institut Curie - Ulm - Paris


According to Clinical.Site data, the most researched conditions in "Institut Curie - Ulm - Paris" are "Advanced Non-small Cell Lung Cancer" (1 trials), "EGFR Mutation" (1 trials), "HER2 Mutation" (1 trials) and "Solid Tumors Harboring NTRK Fusion" (1 trials). Many other conditions were trialed in "Institut Curie - Ulm - Paris" in a lesser frequency.

Clinical Trials Intervention Types at Institut Curie - Ulm - Paris


Most popular intervention types in "Institut Curie - Ulm - Paris" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "BAY2927088_formulation A" (1 trials), "BAY2927088_formulation B_1" (1 trials), "BAY2927088_formulation B_2" (1 trials) and "Larotrectinib (Vitrakvi, BAY2757556)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institut Curie - Ulm - Paris


The vast majority of trials in "Institut Curie - Ulm - Paris" are 2 trials for "All" genders.

Clinical Trials Status at Institut Curie - Ulm - Paris


Currently, there are NaN active trials in "Institut Curie - Ulm - Paris". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institut Curie - Ulm - Paris, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Curie - Ulm - Paris, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 2Phase 1: 2Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 2Recruiting: 2